Exchange: NASDAQ·Updated 07:32 PM EST

About WHWK

About

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
23

Frequently Asked Questions

Advertisement|Remove ads.